Home/ Supplements/ Alpha Lipoic Acid/ OptiGlycemiX Chocolate Mint

OptiGlycemiX Chocolate Mint

product on market Powder XYMOGEN Safety: 97/100
97/100

This product looks safe

  • Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)
  • Vanadium: 2.5mg is 1.4× the Tolerable Upper Intake Level (1.8mg)
  • 48% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The ingredient profile consists of basic macronutrients including proteins, carbohydrates, and fats. There is strong evidence that these components provide essential energy and support general metabolic function. Due to the generic nature of these nutrients, the evidence coverage for specific therapeutic claims is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 40mg is 1.1× the Tolerable Upper Intake Level (35mg)

Vanadium: 2.5mg is 1.4× the Tolerable Upper Intake Level (1.8mg)

Label

Product Label

Label for OptiGlycemiX Chocolate Mint
Open Full PDF View on NIH DSLD →
Details

Label Data

28.5 Gram(s)
Serving Size
14
Servings
Other Combinations
Product Type
48%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
190 {Calories}
Total Fat
4 g (6% DV)
Cholesterol
Total Carbohydrates
22 g (7% DV)
Protein
21 g
50 mg (3333% DV)
41.7× RDA — above typical dose 76 studies (A:0, B:33)
40 mg (200% DV)
Exceeds UL by 1.1× (UL: 35 mg) 196 studies (A:5, B:63)
5 mg (250% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
200 mcg (50% DV)
Within RDA (0.5× RDA) 226 studies (A:10, B:105)
50 mcg (833% DV)
20.8× RDA — above typical dose 139 studies (A:1, B:44)
5000 mcg (1667% DV)
166.7× RDA — above typical dose 27 studies (A:0, B:11)
35 mg (350% DV)
7.0× RDA — above typical dose 2 studies — no high-quality reviews
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
500 mcg (417% DV)
14.3× RDA — above typical dose 199 studies (A:1, B:55)
Sodium
350 mg (15% DV)
Potassium
350 mg (10% DV)
Medium-Chain Triglycerides
1 Gram(s)
Brown Seaweed Blend
500 mg
Cinnamon
200 mg
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
2.5 mg
Exceeds UL by 1.4× (UL: 1.8 mg) 1 studies (A:0, B:1)

Other Ingredients

VegaPro Inulin Cocoa powder evaporated Cane Natural flavors Sunflower Oil Potassium Citrate Sodium Citrate Sodium Chloride Xanthan Gum Guar Gum Stevia leaf extract
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Blend, shake, or briskly stir two level scoops (57 g) of OptiGlycemiX(TM) into 8-12 oz chilled water and consume one to two times daily; or take one to two scoops approximately 30 minutes before each main meal (upper limit of six scoops/day); or use as directed by your healthcare practitioner.

Warnings & Precautions

Keep out of reach of children.

Avoid if pregnant or lactating, or if allergic to any ingredient.

• Pharmaceutical Grade • Professional Use Only

CAUTIONS: Consult your healthcare practitioner before use, especially if you are taking blood-sugar-lowering medications or being treated for diabetes.

Formulation Notes

OptiGlycemiX is a research-based functional food formulated to nutritionally support individuals with insulin/glucose dysregulation and related health issues. It features InSea2(R) - a clinically tested, optimized blend of purified polyphenols from wild-crafted brown seaweed. InSea2 uniquely slows carbohydrate digestion and assimilation and can reduce the impact of high-glycemic foods, resulting in more appropriate glucose and insulin responses. This newly developed, next generation dual carb controller is 100% natural, has an excellent safety profile, and is friendly to the gastrointestinal tract.* OptiGlycemiX also delivers other innovative ingredients, including VegaPro(TM) - a proprietary, sugar-free, sweetener-free, low-allergy-potential source of vegetable protein from pea protein isolate and rice protein concentrate – and CinSulin(R), a concentrated, patented water extract of cinnamon with a potent 10:1 yield ratio. Cinnamon has been studied extensively for its roles in glucose uptake, glycogen synthesis, insulin action, and support for healthy blood lipids. These principal ingredients are complemented by the inclusion of thiamin (as benfotiamine) to boost transketolase activity; alpha-lipoic acid (ALA); green tea leaf extract; vanadium, chromium, and zinc as Albion(R) TRAACS(R) chelates; 5-MTHF (bioactive folate) as Quatrefolic(R); fiber from inulin; and other key vitamins and minerals.* This exclusive combination of well-researched, clinically validated, and highly bioavailable ingredients employs a multi-modal defense against factors that cause blood glucose to rise too quickly, insulin sensitivity to decrease, glycation and oxidative stress to escalate, fat storage to increase, and blood lipids to become altered.*

DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy, animal or dairy products, artificial colors, artificial sweeteners, or preservatives.

Functional Food for Individuals With Insulin/Glucose Dysregualtion Featuring InSea2(R) - Next Generation Carbohydrate Control*

Additional Information

EXCLUSIVE PROFESSIONAL FORMULAS

21g PROTEIN

FUNCTIONAL FOOD

This package is completely recyclable (recycle)

Quatrefolic(TM)

V VegaPro(TM) 100% VEGAN 100% Gluten Free

STORAGE: Keep tightly closed in a cool, dry place.

REV. 100411

Metadata

Product Details

DSLD Entry Date2012-02-23
Product TypeOther Combinations
FormPowder
BrandXYMOGEN
DSLD ID5957
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.